[2-(1H-imidazol-1-yl)phenyl]amine hydrochloride, 95.0%, 25g

1-(5-Tert-butyl-2-hydroxyphenyl)ethan-1-one, 97%, 500mg

Phe-Phe-OMe�HCl, 98.0%, 1g

endo-3-(Diphenylmethoxy)-8-methyl-8-Azabicyclo[3.2.1]octane methanesulfonate, 98.0%, 1g

N-Hydroxysuccinimide, min. 99%, for synthesis, 500 g, glass packaging

(S)-Ethyl 2-acetamido-3-(4-hydroxy-3,5-diiodophenyl)propanoate, 95+%, 25g

4-Aminothiobenzamide, 98.0%, 5g

(S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea, 98.0%, 50mg

2-Butylfuran>98.0%(GC)5g

(S)-6-(4-CHLOROPHENYL)-N-(1-HYDROXYPROPAN-2-YL)-2-(1-METHYL-1H-PYRAZOL-4-YL)-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDE, 95%, 5mg

2-((Tert-butoxycarbonyl)amino)-3-(4-methyl-1H-indol-3-yl)propanoic acid, 95+%, 500mg

1,4-Bis(trimethylsilyl)benzene>97.0%(GC)5g

2,5-Dichloropyridine, 98.0%, 1kg